Armitage Lecture 2011: The design and analysis of life history studies

Statistics in Medicine

Volumn 32, Issue 13, 2013, Pages 2155-2172

  Lawless, Jerald F ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Heterogeneity; Incomplete data; Intermittent observation; Markov processes; Multistate models

Indexed keywords

ARTICLE; CHILD DEVELOPMENT; EDUCATION; EMPLOYMENT; FERTILITY; FOLLOW UP; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; LIFE EVENT; LIFE HISTORY; LIFESPAN; LONGITUDINAL STUDY; OUTCOME ASSESSMENT; STUDY DESIGN;

ANIMALS; COHORT STUDIES; HUMANS; LIFE CYCLE STAGES; LONGITUDINAL STUDIES; MODELS, THEORETICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84877619575     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5754     Document Type: Article

References (60)

1. Hajducek DM, Lawless JF. Duration analysis in longitudinal studies with intermittent observation times and losses to followup. Canadian Journal of Statistics 2012; 40(1):1-21. DOI: 10.1002/cjs.10139.
2. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, for the Women's Health Initiative Investigators. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative Clinical Trial. American Journal of Epidemiology 2005; 162(5):404-414. DOI: 10.1093/aje/kwi222.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993; 329(14):977-986.
4. Barrett JK, Siannis F, Farewell VT. A semi-competing risks model for data with interval-censoring and informative observation: an application to the MRC cognitive function and ageing study. Statistics in Medicine 2011; 30:1-10. DOI: 10.1002/sim.4071.
5. Raina PS, Wolfson C, Kirkland SA, Griffith LE, Oremus M, Patterson C, Tuokko H, Penning M, Ballion CM, Hogan D, Wister A, Payette H, Shannon H, Brazil K. The Canadian Longitudinal Study on Aging (CLSA). Canadian Journal on Aging 2009; 28:221-229. DOI: 10.1017/SO714980809990055.
6. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 1991; 98(Suppl):823-833.
7. Al-Kateb H, Boright AP, Mirea L, Xie X, Sutradhar R, Mowjoodi A, Bharaj B, Liu M, Bucksa JM, Arends VL, Steffes MW, Cleary PA, Sun W, Lachin JM, Thorner PS, Ho M, McKnight AJ, Maxwell AP, Savage DA, Kidd KK, Kidd JR, Speed WC, Orchard TJ, Miller RG, Sun L, Bull SB, Paterson AD, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study. Diabetes 2008; 57:218-228. DOI: 10.2337/db07-1059.
8. The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Opthalmology 1995; 102:647-661.
9. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Archives of Opthalmology 1998; 116:874-887.
10. Cook RJ, Lawless JF. Statistical issues in modeling chronic disease in cohort studies. To appear in Statistics in Bioscience 2013.
11. Raboud JM, Loutfy MR, Su D, Bayoumi AM, Klein MB, Cooper C, Machouf N, Rourke S, Walsmley S, Rachilis A, Harrigan PR, Smieja M, Tsoukas C, Montaner JS, Hogg RS, CANOC Collaboration. Regional differences in rates of HIV-1 viral load monitoring in Canada: insights and implications for antiretroviral care in high income countries. BMC Infectious Diseases 2010; 10:1-9. DOI: 10.1186/1471-2334-10-40.
12. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. Springer-Verlag: New York, 1993.
13. Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, Machouf N, Montaner JS, Rourke S, Tsoukas C, Hogg RS, Raboud J, CANOC Collaboration. Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis. Journal of Infectious Diseases 2012; 205:1230-1238. DOI: 10.1093/infdis/jis104.
14. Cook RJ, Lawless JF. The Statistical Analysis of Recurrent Events. Springer Science + Business Media, LLC: New York, 2007.
15. Cook RJ, Lawless JF, Lakhal-Chaieb L, Lee K-A. Robust estimation of mean functions and treatment effects for recurrent events under event-dependent censoring and termination: application to skeletal complications in cancer metastatic to bone. Journal of the American Statistical Association 2009; 104:60-75. DOI: 10.1198/jasa.2009.0004.
16. Bellhouse DR. A new look at Halley's life table. Journal of the Royal Statistical Society A 2011; 174:823-832.
17. Fix E, Neyman J. A simple stochastic model of recovery, relapse, death and loss of patients. Human Biology 1951; 23:205-241.
18. Blumen L, Kagan M, McCarthy PJ. The Industrial Mobility of Labor as a Probability Process. Cornell University Press: Ithaca NY, 1955.
19. Coleman JS. Introduction to Mathematical Sociology. Free Press of Glencoe: New York, 1964.
20. Aalen OO, Borgan O, Gjessing HK. Survival and Event History Analysis: A Process Point of View. Springer Science + Business Media, LLC: New York, 2008.
21. Cox DR, Isham V. Point Processes. Chapman and Hall: London, 1980.
22. Daley DJ, Vere-Jones D. An Introduction to the Theory of Point Processes. Springer: New York, 1988.
23. Mandel M. Estimating disease progression using panel data. Biostatistics 2010; 11:304-316. DOI: 10.1093/biostatistics/kxp057.
24. Farewell VT, Su L. A multi-state model for events defined by prolonged observation. Biostatistics 2011; 12:102-111. DOI: 10.1093/biostatistics/kxq041.
25. Callegaro M. Seam effects in longitudinal surveys. Journal of Official Statistics 2008; 24:387-409.
26. McKeown K, Jewell NP. Current status observation of a three-state counting process with applications to simultaneous accurate and diluted HIV test data. Canadian Journal of Statistics 2011; 39:475-487. DOI: 10.1002/cjs.10112.
27. Prentice RL. Chronic disease prevention research methods and their reliability, with illustrations from the Women's Health Initiative. Journal of the American Statistical Association 2010; 105:1431-1443. DOI: 10.1198/jasa.tm10570.
28. Prentice RL, Huang Y. Measurement error modeling and nutritional epidemiology association analyses. Canadian Journal of Statistics 2011; 39:498-509. DOI: 10.1002/cjs.10116.
29. Farewell VT, Lawless JF, Gladman DD, Urowitz MB. Analysis of the effect of lost-to-followup on the estimation of mortality from patient registry data. Applied Statistics 2003; 52:445-456.
30. Chen B, Yi GY, Cook RJ. Analysis of interval-censored disease progression data via multi-state models under a nonignorable inspection process. Statistics in Medicine 2010; 29(11):1175-1189. DOI: 10.1002/sim.3804.
31. Sweeting MJ, Farewell VT, De Angelis D. Muliti-state Markov models for disease progression in the presence of informative examination times. Statistics in Medicine 2010; 29:1161-1174. DOI: 10.1002/sim.3812.
32. Glymour MM. When bad genes look good-APOE*E4, cognitive decline and diagnosis thresholds. American Journal of Epidemiology 2007; 165:1239-1246. DOI: 10.1093/aje/kwm092.
33. Pyy-Martikainen M, Rendtel U. Assessing the impact of initial nonresponse and attrition in the analysis of unemployment duration with panel surveys. Advances in Statistical Analysis 2008; 92:297-318. DOI: 10.1007/S10182-008-0069-y.
34. Steele F, Durrant GB. Alternative approaches to multilevel modelling of survey non-contact and refusal. International Statistical Review 2011; 79:70-91. DOI: 10.2307/41306165.
35. Jiang Y, Scott AJ, Wild CJ. Adjusting for non-response in population-based case-control studies. International Statistical Review 2011; 79:145-159. DOI: 10.1111/j.1751-5823.2011.00132.x.
36. Kalbfleisch JD, Lawless JF. The analysis of panel data under a Markov assumption. Journal of the American Statistical Association 1985; 80(392):863-871.
37. Titman AC. Flexible nonhomogeneous Markov models for panel observed data. Biometrics 2011; 67:780-787. DOI: 10.1111/j.1451-0421.2010.01550.x.
38. Jackson CH. Multi-state models for panel data: the msm package for R. Journal of Statistical Software 2011; 38(8):1-28.
39. Tom BDM, Farewell VT. Intermittent observation of time-dependent explanatory variables: a multistate modelling approach. Statistics in Medicine 2011; 30(30):3520-3531. DOI: 10.1002/sim.4429.
40. Andersen PK, Klein JP, Rosthoj S. Generalized linear models for correlated pseudo-observations, with applications to multi-state models. Biometrika 2003; 90:15-27.
41. Titman AC, Sharples LD. Model diagnostics for multi-state models. Statistical Methods in Medical Research 2010; 19:621-651. DOI: 10.1177/0962280209105541.
42. Hwang W, Brookmeyer R. Design of panel studies for disease progression with multiple stages. Lifetime Data Analysis 2003; 9:261-274.
43. Lawless JF, Nazeri Rad N. Estimation and assessment of Markov multistate models with intermittent observations on individuals, 2013. Manuscript.
44. Aalen OO, Borgan O, Fekjaer H. Covariate adjustment of event histories estimated with Markov chains: the additive approach. Biometrics 2001; 57:993-1001.
45. Datta S, Satten GA. Validity of the Aalen-Johansen estimators of stage occupation probabilities and Nelson-Aalen estimators of integrated transition hazards for non-Markov models. Statistics and Probability Letters 2001; 55:403-411.
46. Datta S, Satten GA. Estimation of integrated transition probabilities for non-Markov systems under dependent censoring. Biometrics 2002; 58:792-802.
47. Satten GS, Sternberg MR. Fitting semi-Markov models to interval-censored data with unknown initiation times. Biometrics 1999; 53:507-513.
48. Titman AC, Sharples LD. Semi-Markov models with phase-type sojourn distributions. Biometrics 2010; 66(3):742-752. DOI: 10.1111/j.1541-0420-2009.01339.x.
49. Lawless JF, Nazeri Rad N. Multistate modelling and predictive model assessment, with application to viral rebounds in an HIV-positive cohort, 2013. Manuscript.
50. Hogan JW, Roy J, Korkontzelou C. Tutorial in biostatistics: handling drop-out in longitudinal studies. Statistics in Medicine 2004; 23:1455-1497. DOI: 10.1002/sim.1728.
51. Robins JM, Rotnitzky A, Zhao LP. Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. Journal of the American Statistical Association 1995; 90(429):106-121.
52. Brookmeyer R, Gail MH. AIDS Epidemiology: A Quantitative Approach. Oxford University Press: Oxford, 1994.
53. O'Keeffe AG, Tom BDM, Farewell VT. Mixture distributions in multi-state modelling: some considerations in a study of psoriatic arthritis. Statistics in Medicine 2012; 32:600-619. DOI: 10.1002/sim.5529.
54. Lawless JF, Fong DYT. State duration models in clinical and observational studies. Statistics in Medicine 1999; 18:2365-2376.
55. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alheimer's disease. Alzheimers and Dementia 2007; 3:186-191.
56. Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, Kryscio RJ. Transitions to mild cognitive impairments, dementia, and death: findings from the nun study. American Journal of Epidemiology 2007; 165(11):1231-1238. DOI: 10.1093/aje/kwm085.
57. Cook RJ, Lawless JF, Lee K-A. Cumulative processes related to event histories. Statistics and Operations Research Transactions 2003; 27:13-29.
58. Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M. Using the whole cohort in the analysis of case-cohort data. American Journal of Epidemiology 2009; 169:1398-1405. DOI: 10.1093/aje/kwp055.
59. Mueller PW, Rogus JJ, Clearly PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors in diabetic nephropathy in type 1 diabetes. Journal of the American Society of Nephrology 2006; 17:1782-1790. DOI: 10.1681/ASN.2005080822.
60. Sun J. The Statistical Analysis of Interval-censored Failure Time Data. Springer: New York, 2006.